- 著者
- Koichi Inoue Tomoyuki Fujita Daisuke Yoshioka Kohei Tonai Yusuke Yanagino Takashi Kakuta Naoki Tadokoro Naonori Kawamoto Kizuku Yamashita Ai Kawamura Ryohei Matsuura Takuji Kawamura Tetsuya Saito Masashi Kawamura Satoshi Kainuma Satsuki Fukushima Koichi Toda Shigeru Miyagawa
- 出版者
- The Japanese Circulation Society
- 雑誌
- Circulation Journal (ISSN:13469843)
- 巻号頁・発行日
- vol.86, no.12, pp.1961-1967, 2022-11-25 (Released:2022-11-25)
- 参考文献数
- 21
- 被引用文献数
- 2
Background: The superiority of a fully magnetically levitated centrifugal-flow left ventricular assist device (LVAD) in terms of overall survival, stroke events and pump thrombosis has been demonstrated in previous international analyses, so we evaluated a Japanese cohort for the same.Methods and Results: This retrospective observational study was conducted at Osaka University Medical Hospital and the National Cerebral and Cardiovascular Center in Japan. A total of 75 consecutive patients who underwent HeartMate3 (HM3) implantation were included. The primary endpoint was on-device survival, and the secondary endpoint was the incidence of LVAD-related complications at 2 years. All parameters were compared with those of the previously performed HeartMate II (HMII) implantation in 197 cases. The on-device survival rates were 94.7% and 92.3% in the HM3 and HMII groups, respectively, at the 2-year follow-up (P=0.62). The rehospitalization-free rate after implantation was 61.8% in the HM3 group, which was significantly higher than that in the HMII group (relative risk, 0.35; 95% confidence interval [CI], 0.23–0.55; P<0.0001). Event-free survival rates from cerebral cerebrovascular events and pump thrombosis in the HM3 group were significantly higher than those in the HMII group, at 97.2% and 100%, respectively (relative risk, 0.14; 95% CI 0.03–0.58); P=0.0015 and relative risk, not calculated; P=0.049, respectively).Conclusions: Satisfactory short-term outcomes were observed after HM3 implantation in a Japanese cohort.
- 著者
- Masahiro MIKURIYA Junya YAMAMOTO Kazuya OUCHI Daisuke YOSHIOKA Hidekazu TANAKA Makoto HANDA
- 出版者
- (社)日本分析化学会
- 雑誌
- X-ray Structure Analysis Online (ISSN:18833578)
- 巻号頁・発行日
- vol.29, pp.45-46, 2013 (Released:2013-11-18)
- 参考文献数
- 10
- 被引用文献数
- 5
The title compound, a chain adduct of rhodium(II) benzoate with 1,4-diazabicyclo[2.2.2]octane (dabco), catena(tetrakis(μ-benzoato-O,O′)(μ-1,4-diazabicyclo[2.2.2]octane-N,N′)dirhodium(II)-acetonitrile(1/4)), [Rh2(C6H5CO2)4(dabco)]n·4nCH3CN, was isolated. The crystal structure was determined by the single-crystal X-ray diffraction method at 293 K. It crystallizes in the tetragonal space group P4/n with a = 21.3695(18)Å, c = 9.6278(12)Å, V = 4396.6(8)Å3, Dx = 1.468 g/cm3, and Z = 4. The R1 [I > 2σ(I)] and wR2 (all data) values are 0.0417 and 0.0825, respectively, for all 5185 independent reflections. The molecule has a linear chain with an alternating arrangement of Rh2(C6H5CO2)4 [Rh-Rh 2.4062(11)Å, 2.4110(11)Å] and dabco. The adsorption property was confirmed for N2 gas with a specific surface area of 387.8 m2 g-1 estimated from an N2 adsorption isotherm.
- 著者
- Hiroki Hata Toru Kuratani Takashi Shibuya Koichi Toda Takayoshi Ueno Shigeru Miyagawa Yasushi Yoshikawa Kazuo Shimamura Keiwa Kin Daisuke Yoshioka Masaki Taira Koichi Maeda Keitaro Domae Yoshiki Sawa
- 出版者
- The Japanese Circulation Society
- 雑誌
- Circulation Journal (ISSN:13469843)
- 巻号頁・発行日
- pp.CJ-18-0687, (Released:2018-06-28)
- 参考文献数
- 12
The 82nd Annual Scientific Meeting of the Japanese Circulation Society was held in Osaka, Japan, on March 23–25, 2018, when the cherry blossoms were just opening everywhere around the venue. This was the 5th Annual Scientific Meeting of JCS in which a cardiovascular surgeon served as Congress Chairperson. The main theme of this meeting was “Futurability: Pioneering the Future of Circulatory Medicine”. The word, futurability, is a neologism of future ability, because we now have to contemplate what constitutes the essence of cardiovascular medicine, how it should develop as medicine for future generations, and how its ability should be displayed. The meeting was favored by splendid weather and the number of participants was recorded as being higher than 18,700. There were heated and profound discussions about the “futurability” of cardiology, cardiovascular surgery, and heart team medical care as well, in every session. The meeting was successfully completed and we sincerely appreciate the great cooperation and support from all affiliates.